Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Digestive Disorder

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1260074

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1260074

Yersinia Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Description

Table of Contents

List of Tables

Yersinia is a gram-positive bacteria causing terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children, and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, North Europe, and Scandinavian counties, making these regions the largest markets for Yersinia diagnostics. Furthermore, greater adoption of novel molecular diagnostic tools and higher awareness also contribute to the dominance of these markets. On the other hand, the Asia Pacific Yersinia diagnostics market holds great potential due to the wide presence of untapped opportunities in emerging Asian countries and the significantly high prevalence of Yersinia infection in Japan.

Treatment of Yersinia infections includes drugs such as aminoglycosides, cephalosporins, tetracyclines, trimethoprim-sulfamethoxazole (TMP-SMZ), and fluoroquinolones. The diagnostic methods used include ELISA, tube agglutination, radioimmunoassay, ultrasonography, stool culture, CT scan, and colonoscopy. Definite detection of Yersinia enterocolitica isolates can also be performed through sequencing of the 16S rRNA gene. Immunoblot with plasmodial encoded Yersinia protein also enables serological identification. However, developing more sensitive, efficient, and yet simple rapid diagnostic systems that can be applied to direct and indirect diagnosis remains a challenge in this market.

Key players identified for the Yersinia Diagnostics market include but are not limited to:

Abbott Laboratories, Inc., Affymetrix, Inc., Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann La-Roche, Gen-probe, Hologic, Thermo Fisher Scientific, and Other notable players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Yersinia Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Yersinia Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

Stool Culture

ELISA

Radioimmunoassay

Tube Agglutination

CT Scan

Ultrasonography

Colonoscopy

Technology

DNA Probes

Immunoassay

Monoclonal Antibodies

PCR

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Yersinia Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Yersinia Diagnostics market?

Which is the largest regional market for Yersinia Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Yersinia Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Yersinia Diagnostics market worldwide?

Show more
Product Code: 137967-01-23

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Yersinia Diagnostics Market
  • 2.2. Global Yersinia Diagnostics Market, By Test, 2022 (US$ Million)
  • 2.3. Global Yersinia Diagnostics Market, By Technology, 2022 (US$ Million)
  • 2.4. Global Yersinia Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Yersinia Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Yersinia Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Yersinia Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Yersinia Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Yersinia Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Stool Culture
    • 5.3.2. ELISA
    • 5.3.3. Radioimmunoassay
    • 5.3.4. Tube Agglutination
    • 5.3.5. CT Scan
    • 5.3.6. Ultrasonography
    • 5.3.7. Colonoscopy

6. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. DNA Probes
    • 6.3.2. Immunoassay
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. PCR
    • 6.3.5. Others

7. North America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 7.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 7.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

8. UK and European Union Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 8.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 8.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

9. Asia Pacific Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 9.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 9.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

10. Latin America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 10.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 10.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

11. Middle East and Africa Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 11.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 11.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Affymetrix, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Becton Dickinson
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Bio-Rad Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Danaher Corporation
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. F. Hoffmann La-Roche
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Gen-probe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Hologic
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Thermo Fisher Scientific
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Other notable players
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
Show more
Product Code: 137967-01-23

List of Tables

  • TABLE 1 Global Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 2 Global Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 3 North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 4 North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 5 U.S. Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 6 U.S. Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 7 Canada Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 8 Canada Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 13 UK Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 14 UK Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 15 Germany Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 16 Germany Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 17 Spain Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 18 Spain Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 19 Italy Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 20 Italy Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 21 France Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 22 France Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 25 Asia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 26 Asia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 27 China Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 28 China Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 29 Japan Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 30 Japan Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 31 India Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 32 India Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 33 Australia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 34 Australia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 35 South Korea Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 36 South Korea Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 37 Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 38 Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 39 Brazil Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 40 Brazil Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 41 Mexico Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 42 Mexico Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 47 GCC Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 48 GCC Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 49 Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 50 Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Yersinia Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Yersinia Diagnostics Market: Quality Assurance
  • FIG. 5 Global Yersinia Diagnostics Market, By Test, 2022
  • FIG. 6 Global Yersinia Diagnostics Market, By Technology, 2022
  • FIG. 7 Global Yersinia Diagnostics Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Yersinia Diagnostics Market, 2022
  • FIG. 9 Market Positioning of Key Yersinia Diagnostics Market Players, 2022
  • FIG. 10 Global Yersinia Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Yersinia Diagnostics Market, By Test, 2022 Vs 2031, %
  • FIG. 12 Global Yersinia Diagnostics Market, By Technology, 2022 Vs 2031, %
  • FIG. 13 U.S. Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 France Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 China Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 India Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!